Funding Received
$41.8 Million in 2 Rounds from 7 Investors
Most Recent Funding
$30 Million on September 5, 2012 / Undisclosed Round
Headquarters:
Manchester
Description:
F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.
Categories:
Biotechnology
Website:
http://www.f2g.com

Company Details

Update

F2G is advancing its own patented compounds and technologies which will lead to the development of novel agents to treat serious fungal disease. The Company was founded on its proprietary genomics technology (MycoBank®) that identifies essential gene targets in fungi. Having received initial funding in 2002 the company then rapidly diversified into chemistry-driven discovery. They have also assembled an experienced development capacity.

Current Team (10)

Update

Past Team (1)

Update

Board Members and Advisors (4)

Update

Investors (7)

Update

Offices/Locations (1)

Update
  • Office

    PO Box 1, Lankro Way, Eccles

    Manchester, M30 0BH

    GBR

Images (1)

Update
  • C8bc8a7763845c757e45fd8e918e6ef4